Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 214 (3), 761-8

Determining the Subjective and Physiological Effects of BZP Combined With TFMPP in Human Males

Clinical Trial

Determining the Subjective and Physiological Effects of BZP Combined With TFMPP in Human Males

Joanne C Lin et al. Psychopharmacology (Berl).


Rationale: ‘Party Pills’ containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) have been used in a recreational context since the 1990s and, prior to April 2008, were legally available in New Zealand. Taken together, they have been reported to produce a ‘high’ similar to that produced by 3,4-methylenedioxymethamphetamine (MDMA).

Objectives: There has been little research on the subjective effects of piperazines in humans. The purpose of this study is to further investigate the subjective and physiological responses following an oral dose of BZP combined with TFMPP in males.

Methods: In a randomised, double-blind, placebo-controlled study the subjective and physiological effects of BZP/TFMPP were investigated in 36 healthy, non-smoking males (mean age 22 ± 4 years). Participants were tested before and approximately 120 min after administration of a single dose of placebo (n = 16) or 100/30 mg BZP/TFMPP (n = 20). Participants were required to comment on the subjective effects using three rating scales—the Addiction Research Centre Inventory (ARCI), the Visual Analogue Scale (VAS) and the Profile of Mood States (POMS). Participants' blood pressure, heart rate and body temperature were also measured.

Results: Statistical analysis using repeated-measures analysis of variance (ANOVA) and planned comparisons revealed that BZP/TFMPP significantly increases blood pressure and heart rate (p < 0.05). Likewise, the subjective rating scales revealed that BZP/TFMPP has significant dexamphetamine-like effects, increases dysphoria and feelings of self-confidence (p < 0.05).

Conclusion: These physiological and subjective data reflect clear similarities between the effects of BZP/TFMPP and commonly known stimulants such as dexamphetamine and MDMA.

Similar articles

See all similar articles

Cited by 5 articles


    1. Addict Behav. 2002 Nov-Dec;27(6):1025-35 - PubMed
    1. Behav Pharmacol. 2002 Jul;13(4):303-11 - PubMed
    1. Eur J Pharmacol. 1989 Jan 2;159(1):41-6 - PubMed
    1. CMAJ. 2001 Oct 2;165(7):917-28 - PubMed
    1. Fundam Clin Pharmacol. 1992;6(8-9):333-41 - PubMed

Publication types

LinkOut - more resources